Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
14.46
Price to sales ratio
4.06
Dividends per share
3.28
Dividend yield %
3.12

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
17
JNJ
Johnson & Johnson Common Stock
258.13 USD+0.43%-0.29%+7.55%+64.64%621.37 B USD
24
ABBV
AbbVie Inc. Common Stock
248.05 USD+0.03%-3.56%+9.32%+29.36%438.25 B USD
44
NVS
Novartis AG
153.53 USD-0.34%-1.32%-0.31%+27.51%292.96 B USD
71
AMGN
Amgen Inc. - Common Stock
359.71 USD-1.01%-1.97%+1.98%+22.41%194.14 B USD

Frequently asked questions about Merck & Company, Inc. Common Stock

What is the Merck & Company, Inc. Common Stock stock price today?

The current price of Merck & Company, Inc. Common Stock (MRK) is 123.66. Over the past 24 hours, the stock has changed by +0.09%. Follow the MRK chart for real-time price dynamics.

What is the stock ticker of Merck & Company, Inc. Common Stock?

Merck & Company, Inc. Common Stock trades under the ticker MRK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Merck & Company, Inc. Common Stock stock going up?

MRK has changed by -2.34% over the last week, +1.78% over the last month, and +48.24% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Merck & Company, Inc. Common Stock release financial reports?

Yes. You can track Merck & Company, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Merck & Company, Inc. Common Stock net income for the last quarter?

Merck & Company, Inc. Common Stock reported net income of -4.24 B for the last quarter. The previous quarter showed 2.96 B, which means net income changed by -243.10%.

How many employees does Merck & Company, Inc. Common Stock have?

As of the latest available data, Merck & Company, Inc. Common Stock has 75 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Merck & Company, Inc. Common Stock EBITDA?

Merck & Company, Inc. Common Stock EBITDA is -1.88 B, and its EBITDA margin is -11.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Merck & Company, Inc. Common Stock stock?

You can buy Merck & Company, Inc. Common Stock (MRK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Merck & Company, Inc. Common Stock stock?

Investing in Merck & Company, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MRK chart and related analysis on metatrader.com as part of your research.

Merck & Company, Inc. Common Stock

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

News